Lack of an effect of human immunodeficiency virus coinfection on the pharmacokinetics of entecavir in hepatitis B virus-infected patients.
about
The Discovery and Development of a Potent Antiviral Drug, Entecavir, for the Treatment of Chronic Hepatitis BAntiviral treatment of chronic hepatitis B virus (HBV) infectionsEntecavir: a review of its use in the treatment of chronic hepatitis B in patients with decompensated liver disease.Pharmacokinetic similarity of biologics: analysis using nonlinear mixed-effects modeling.Model-based analyses of bioequivalence crossover trials using the stochastic approximation expectation maximisation algorithm.LC-MS/MS method for the characterization of the forced degradation products of Entecavir.
P2860
Lack of an effect of human immunodeficiency virus coinfection on the pharmacokinetics of entecavir in hepatitis B virus-infected patients.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Lack of an effect of human imm ...... tis B virus-infected patients.
@en
type
label
Lack of an effect of human imm ...... tis B virus-infected patients.
@en
prefLabel
Lack of an effect of human imm ...... tis B virus-infected patients.
@en
P2093
P2860
P356
P1476
Lack of an effect of human imm ...... tis B virus-infected patients.
@en
P2093
Dennis Grasela
Frank LaCreta
Marc Bifano
Marc Pfister
Yonghua Wang
P2860
P304
P356
10.1128/AAC.01366-07
P407
P577
2008-04-07T00:00:00Z